Biomarin Pharmaceutical Inc Net Asset Momentum
Biomarin Pharmaceutical Inc net asset momentum. Biomarin Pharmaceutical Inc (BMRN) recorded a net asset momentum of 7.6% as of December 2025, with net assets of $6.09 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore BMRN capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Biomarin Pharmaceutical Inc (1998–2025)
Net asset momentum of Biomarin Pharmaceutical Inc from 1998 to 2025. This chart tracks Biomarin Pharmaceutical Inc's year-over-year net asset growth across 28 annual reporting periods from 1998 to 2025. The most recent momentum reading is +7.6%, with net assets of $6.09 Billion USD as of December 2025. See BMRN book value for net asset value and shareholders' equity analysis.
Biomarin Pharmaceutical Inc Net Asset Momentum by Year (1998–2025)
Biomarin Pharmaceutical Inc net asset momentum by year from 1998 to 2025. The table below shows the complete annual net asset history for Biomarin Pharmaceutical Inc from 1998 to 2025, covering 28 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Biomarin Pharmaceutical Inc (BMRN) market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $6.09 Billion | $7.59 Billion | $1.51 Billion | ▲ +7.6% |
| 2024 | $5.66 Billion | $6.99 Billion | $1.33 Billion | ▲ +14.3% |
| 2023 | $4.95 Billion | $6.84 Billion | $1.89 Billion | ▲ +7.6% |
| 2022 | $4.60 Billion | $6.38 Billion | $1.77 Billion | ▲ +7.8% |
| 2021 | $4.27 Billion | $6.00 Billion | $1.73 Billion | ▲ +4.0% |
| 2020 | $4.11 Billion | $5.85 Billion | $1.74 Billion | ▲ +31.5% |
| 2019 | $3.12 Billion | $4.69 Billion | $1.57 Billion | ▲ +5.2% |
| 2018 | $2.97 Billion | $4.43 Billion | $1.46 Billion | ▲ +5.7% |
| 2017 | $2.81 Billion | $4.63 Billion | $1.82 Billion | ▲ +1.5% |
| 2016 | $2.77 Billion | $4.02 Billion | $1.26 Billion | ▲ +15.2% |
| 2015 | $2.40 Billion | $3.73 Billion | $1.33 Billion | ▲ +57.1% |
| 2014 | $1.53 Billion | $2.49 Billion | $962.56 Million | ▲ +13.9% |
| 2013 | $1.34 Billion | $2.24 Billion | $903.02 Million | ▲ +32.0% |
| 2012 | $1.02 Billion | $1.57 Billion | $552.58 Million | ▲ +31.4% |
| 2011 | $773.05 Million | $1.31 Billion | $532.66 Million | ▲ +7.8% |
| 2010 | $717.26 Million | $1.26 Billion | $545.37 Million | ▲ +122.6% |
| 2009 | $322.19 Million | $917.16 Million | $594.98 Million | ▲ +16.4% |
| 2008 | $276.68 Million | $906.70 Million | $630.02 Million | ▲ +47.4% |
| 2007 | $187.73 Million | $815.28 Million | $627.55 Million | ▲ +59.4% |
| 2006 | $117.80 Million | $463.44 Million | $345.63 Million | ▲ +252.1% |
| 2005 | $-77.46 Million | $195.30 Million | $272.76 Million | ▼ -14.0% |
| 2004 | $-67.98 Million | $232.97 Million | $300.94 Million | ▼ -157.7% |
| 2003 | $117.85 Million | $256.34 Million | $138.49 Million | ▲ +19.6% |
| 2002 | $98.54 Million | $110.62 Million | $12.07 Million | ▼ -38.2% |
| 2001 | $159.55 Million | $171.81 Million | $12.26 Million | ▲ +127.9% |
| 2000 | $69.99 Million | $76.93 Million | $6.94 Million | ▼ -28.9% |
| 1999 | $98.38 Million | $103.55 Million | $5.17 Million | ▲ +234.6% |
| 1998 | $29.40 Million | $31.51 Million | $2.11 Million | — |